Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The Molteno implant in intractable glaucoma.

R N Downes1, D W Flanagan, K Jordan

  • 1Department of Ophthalmology, Addenbrookes Hospital, Cambridge.

Eye (London, England)
|January 1, 1988
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Personalised antiemetic prophylaxis with NEPA for patients at high risk of chemotherapy-induced nausea and vomiting receiving moderately emetogenic chemotherapy: results from the randomised, multinational MyRisk trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author

From toxicity assessment to adaptive safety care: implementing comprehensive fast-track safety evaluation for anticancer drug development.

ESMO open·2025
Same author

A taxonomy of the factors contributing to the overtreatment of cancer patients at the end of life. What is the problem? Why does it happen? How can it be addressed?

ESMO open·2025
Same author

Beyond the usual window: persistent nausea with trastuzumab deruxtecan calls for new management strategies.

Annals of oncology : official journal of the European Society for Medical Oncology·2024
Same author

2023 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting.

ESMO open·2024
Same author

MASCC/ESMO antiemetic guidelines: Introduction to the 2023 guidelines update.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2023
Same journal

Tubing the trabeculectomy: a novel filtration technique.

Eye (London, England)·2026
Same journal

Retinal non-perfusion progression in severe non-proliferative and proliferative diabetic retinopathy over time: INSPIRED study report 2.

Eye (London, England)·2026
Same journal

Macular serpiginous choroiditis versus macular serpiginous-like choroiditis: clinical features, outcomes and prognosis.

Eye (London, England)·2026
Same journal

Association of baseline brain care score with the incidence of age-related eye diseases.

Eye (London, England)·2026
Same journal

A comparative analysis of carbon dioxide versus nitrous oxide as the pressurised gas driving a retinal cryotherapy unit.

Eye (London, England)·2026
Same journal

Determinants of regression kinetics in observed stage 3 retinopathy of prematurity without plus disease.

Eye (London, England)·2026
See all related articles

The Molteno seton successfully managed intractable glaucoma in over half of 96 patients, controlling intraocular pressure and stabilizing vision long-term. This glaucoma treatment offers a viable option for patients with severe, difficult-to-treat eye conditions.

Area of Science:

  • Ophthalmology
  • Glaucoma Management
  • Surgical Interventions

Background:

  • Intractable glaucoma presents a significant challenge in ophthalmic care.
  • Effective long-term management strategies are crucial for preserving vision.

Purpose of the Study:

  • To evaluate the long-term efficacy of the Molteno seton in managing intractable glaucoma.
  • To assess intraocular pressure control and visual stabilization outcomes.

Main Methods:

  • Retrospective analysis of 96 cases of intractable glaucoma.
  • Management involved the implantation of a Molteno seton device.
  • Data collected on intraocular pressure and visual acuity over extended periods.

Main Results:

Related Experiment Videos

  • Over 50% of cases achieved satisfactory intraocular pressure control.
  • Visual stabilization was observed in a significant proportion of patients.
  • The Molteno seton demonstrated sustained effectiveness in managing complex glaucoma.

    • Conclusions:

    • The Molteno seton is an effective surgical option for long-term management of intractable glaucoma.
    • Satisfactory outcomes in terms of IOP control and visual stabilization were achieved in over half of the studied cases.
    • This intervention offers a valuable therapeutic approach for patients with severe glaucoma unresponsive to other treatments.